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Abstract Anhedonia is a prominent symptom in neuropsy-
chiatric disorders, most markedly in major depressive disorder
(MDD) and schizophrenia (SZ). Emerging evidence indicates
an overlap in the neural substrates of anhedonia between
MDD and SZ, which supported a transdiagnostic approach.
Therefore, we used activation likelihood estimation (ALE)
meta-analysis of functional magnetic resonance imaging stud-
ies in MDD and SZ to examine the neural bases of three
subdomains of anhedonia: consummatory anhedonia, antici-
patory anhedonia and emotional processing. ALE analysis
focused specifically on MDD or SZ was used later to dissoci-
ate specific anhedonia-related neurobiological impairments
from potential disease general impairments. ALE results
revealed that consummatory anhedonia was associated with
decreased activation in ventral basal ganglia areas, while an-
ticipatory anhedonia was associated with more substrates in
frontal-striatal networks except the ventral striatum, which in-
cluded the dorsal anterior cingulate, middle frontal gyrus and
medial frontal gyrus. MDD and SZ patients showed similar neu-
robiological impairments in anticipatory and consummatory an-
hedonia, but differences in the emotional experience task, which
may also involve affective/mood general processing. These re-
sults support that anhedonia is characterized by alterations in
reward processing and relies on frontal-striatal brain circuitry.
The transdiagnostic approach is a promising way to reveal the
overall neurobiological framework that contributes to anhedonia
and could help to improve targeted treatment strategies.
Keywords Anhedonia . Activation likelihood estimation
(ALE) .Meta-analysis . Transdiagnostic . Major depressive
disorder . Schizophrenia
Introduction
Anhedonia is defined as ‘markedly diminished interest or
pleasure in all, or almost all, activities most of the day,
nearly every day’ (Association and Association 1994).
Although anhedonia has long been considered a promi-
nent symptom in neuropsychiatric disorders, especially
major depressive disorder (MDD) and schizophrenia
(SZ) (Association and Association 1994), its underlying
neurobiological mechanisms remain poorly understood.
Recently, evidence has emerged to indicate overlap of
behavioral, cognitive processing and neurobiological ab-
normalities between MDD and SZ patients with marked
clinical anhedonia (Gradin et al. 2011; Whitton et al.
2015). As a result of this finding and the advocacy of
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the NIMH Research Domain Criteria (RDoC) project
(Insel et al. 2010), investigators are seeking to use the
basic behavioral dimension of functioning, rather than
t r a d i t i o n a l d i a gno s t i c c a t e go r i e s , t o i d e n t i f y
transdiagnostic neural markers of anhedonia (Corral-
Frias et al. 2015; Cuthbert and Insel 2013; Markou et al.
2009). A quantitative meta-analysis of pooled neuroim-
aging studies of anhedonia in MDD and SZ, discussed
within the RDoC framework, is a promising approach to
investigate the neural substrates of anhedonia. However,
it is important to be mindful of the complexity and multi-
faceted nature of clinical anhedonia to understand neuro-
imaging studies in this field.
Based on the latest studies, anhedonia is a multidimen-
sional construct and should not simply be considered as
‘loss of an ability to experience pleasure’. Deficits in oth-
er reward processes, such as valuation, motivation and
decision-making, may lead to behaviors that can be
interpreted as anhedonia (Der-Avakian and Markou
2012; Gold et al. 2008; Leventhal et al. 2006). Hence,
distinguishing the deficits in different cognitive subcom-
ponents of anhedonia is essential to identify its neurobi-
ological substrates. Some investigators have suggested
dichotomizing anhedonia into ‘consummatory anhedo-
nia’ (the hedonic response to rewards) and ‘anticipatory
anhedonia’ (diminished motivation to pursue rewards)
(Treadway and Zald 2011). Others hold that studies
should move away from conceptualization of anhedonia
as a steady-state, mood-like phenomena, and instead fo-
cus on the reward-related motivational/decisional-
making aspect (Treadway et al. 2012; Whitton et al.
2015). Still others propose to bridge the gap between pre-
clinical and clinical studies by isolating the neural sub-
strates of various processes, such as sensing a pleasant
stimulus or anticipating expected rewards, computing
value and associated costs, determining effort required,
deciding to obtain the reward, increasing motivation and
performing the action (Der-Avakian and Markou 2012).
Changing research strategies and models demand more
complicated and elaborate experimental designs to inves-
tigate the underlying neural bases of anhedonia.
Several experimental paradigms have been developed
in last decade to explore the specific processes of anhe-
donia beyond hedonic capacity, such as anticipation, mo-
tivation and reinforcement learning. However, only a few
task-based functional magnetic resonance imaging
(fMRI) studies have separated anhedonia deficits into dif-
ferent processing stages. Early neuroimaging studies fre-
quently adopted the passive picture-viewing task based
on the viewpoint that anhedonia represents a diminished
responsiveness to positive-valence stimuli (Hooker et al.
2014; Mitterschiffthaler et al. 2003; Shi et al. 2013). More
recent ly, some exper imenta l reward parad igms,
especially the monetary incentive delay task (MID)
(Admon et al. 2015; Balodis and Potenza 2015; Elman
et al. 2009), have been increasingly used to detect neural
substrates of anhedonia. Those studies have typically ex-
plored brain act ivi ty impairments in experience/
consummatory and motivational/anticipatory stages sep-
arately, and they discussed the link between anhedonia
and the reward-processing components of ‘liking’ and
‘wanting’ from the preclinical literature (Berridge and
Robinson 2003; Dillon et al. 2008). Specifically, the con-
summatory stage was primarily associated with dysfunc-
tions of reward coding and evaluation, and the anticipa-
tory stage was associated with advanced cognitive func-
tions, such as motivation and decision-making. Recently,
although other paradigms have been developed to assess a
specific aspect of anhedonia-related processing, such as
the Effort Expenditure for Rewards Task (EEfRT), which
focuses on motivation and effort-based decision-making
(Fervaha et al. 2013; Treadway et al. 2009; Yang et al.
2014) and the Probabilistic Learning Task (PRT), which
focuses on reward learning (Pizzagalli et al. 2008), no neu-
roimaging studies have used these two paradigms in MDD
or SZ patients. In fact, to date the majority of studies have
explored the neurobiology of the three subdomains of an-
hedonia, which involve different neurocognitive process
and functional neuroanatomy bases: consummatory anhe-
donia, anticipatory anhedonia and emotional (positive stim-
uli) processing (Berridge and Robinson 2003; Dillon et al.
2008; Smoski et al. 2011).
Neuroimaging studies of the three subdomains of anhe-
donia in MDD and SZ patients have reached inconsistent
and even contradictory findings. For instance, several
studies that used a reward-related task, most often MID,
indicated ventral striatal blunting in depressed adults
(Knutson et al. 2008; Kumar et al. 2008; Ubl et al. 2015)
and even in never-depressed youth with family history of
MDD (Gotlib et al. 2010). Another study using the same
experimental paradigm (MID) showed no significant
group difference in ventral striatum between unmedicated
MDD and controls after correction (Pizzagalli et al. 2009).
Furthermore, Pizzagalli et al. (2008) reported decreased
activation in dorsal anterior cingulate (dACC) during the
MID task in MDD patients compared with healthy con-
trols, whereas other studies found increased activation of
dACC in MDD (Gorka et al. 2014; Knutson et al. 2008).
Similar contradictory results have been observed in SZ
patients, especially in the experience/consummatory
stage. When presented with reward stimuli, SZ patients
showed impairments in both ventral striatal and prefrontal
areas (da Silva Alves et al. 2013; Walter et al. 2009a),
impairments in prefrontal cortex but not basal ganglia
areas (Waltz et al. 2010) or no impairments in either area
(Mucc i e t a l . 2015 ; S imon e t a l . 2010) . These
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inconsistencies among studies may reflect differences in
sample size, sample characteristics (average age, sexual
ratio, medicated or not), paradigms used, and fMRI anal-
ysis methods.
The development of meta-analyses methods for neu-
roimaging data provide a valuable tool for combining
data across diverse studies and building consensus in
identification of neuroanatomical correlates of specific
behavior. To date, the main methods used for the meta-
analyses of neuroimaging data could be divided into two
categories: the regions of interest (ROI) based meta-
analytic methods, and the voxel-based meta-analytic
methods. The ROI-based methods allow for optimal sta-
tistical analyses but are based on a priori hypotheses
therefore being affected by a limited and potentially bi-
ased inclusion of brain regions (Rotge et al. 2009; Radua
and Mataix-Cols 2012). On the other hand, voxel-based
methods have a more exhaustive and unbiased inclusion
of studies but have some stat is t ical ly l imitat ion.
Activation likelihood estimation (ALE), proposed by
Turkeltaub and Laird (Turkeltaub et al. 2002; Laird
et al. 2005), is probably the most common algorithm for
voxel-based meta-analyses.
Besides the clear mathematical logic and operation
steps, ALE method has several advantages over ROI-
based meta-analyses through inputting the foci of activa-
tion instead of labels, weighting the foci by the number of
participants in each study, yielding a quantitative estimate
of the probability of activation, identifying common acti-
vations across different studies (Laird et al. 2005; Wager
et al. 2007; Eickhoff et al. 2009; Eickhoff et al. 2012).
More importantly, the recent change from fixed-effects
to random-effects inference in analyses (Eickhoff et al.
2009) and the revision for multiple comparison correction
(Eickhoff et al. 2012) made ALE to become a more reli-
able statistic meta-analysis approach.
Therefore, the ALE meta-analysis method was used in this
review to make an objective, systematic, and quantitative
analysis of the previous literature and synthesize the anhedo-
nia-related, task-based fMRI findings in MDD and SZ from
three subdomains of anhedonia: consummatory anhedonia,
anticipatory anhedonia, and emotional processing.
Specifically, we first performed the within-group ALE meta-
analyses to provide a context for interpreting the anhedonia-
related between-group differences. In the between-group anal-
ysis, the transdiagnostic ALE analysis of the literature on
MDD and SZ was examined to provide an integrated frame-
work of the neural bases of anhedonia, and the analysis fo-
cused specifically on MDD or SZ was used later to dissociate
specific anhedonia-related neurobiological impairments from
potential disease general impairments. The transdiagnostic ap-
proach provides the opportunity to identify an overall neuro-
biological framework for a specific symptom or behavior
across multiple disease states and has the potential to improve
targeted treatment strategies.
Methods
Data sources
Studies focused on the neurobiology of anhedonia in pa-
tients with MDD or SZ were identified through comput-
erized literature searches using PubMed and Web of
Science. We reviewed all papers published in the
English language up to August 1, 2015. The key words
used for the search were ‘anhedonia’, ‘hedonic’, ‘emo-
tional withdrawal’, ‘pleasure deficit’, ‘apathetical social
withdrawal’ , ‘functional magnetic resonance’ and
‘fMRI’. A total of 571 English publications were initially
identified using this process. Another three articles were
obtained from reference lists of prior reviews (Whitton
et al. 2015; Zhang et al. 2013). In summary, these search
procedures yielded an initial pool of 574 potential articles
for inclusion.
In prior neuroimaging studies focused on anhedonia,
the most common paradigms adopted were the MID, re-
inforcement learning task (RLT) and emotional experi-
ence task (EET). For MID, RLT or some modified reward
tasks, subjects initially see a cue indicating that they will
have an opportunity to obtain a certain amount of reward
(e.g., money), then they perform a task, and they receive
immediate feedback (by obtaining or not obtaining the
reward). The process between the cue and the task refers
to anticipation stage, and the in-the-moment experience
during receipt of a reward refers to consummatory stage.
Besides, the emotional experience task (EET) is associat-
ed with a passive viewing of positive-valence stimuli that
requires no response. Therefore, based on different cog-
ni t ive process , we divided anhedonia into three
subdomains: anticipatory anhedonia, consummatory an-
hedonia, and emotional processing.
Inclusion criteria
For the current meta-analysis, once duplicate articles
were removed, the following eight inclusion criteria were
utilized: (1) first-hand empirical studies; (2) subjects were
healthy controls or patients with either MDD or SZ; (3)
MDD or SZ were diagnosed according to DSM-IV(−TR)
or ICD-10; (4) studies focused on anhedonia though task-
related paradigms; (5) studies examined neuronal activity
related to anhedonia using fMRI; (6) studies identified
foci of task-related neural changes in active conditions
(e.g., emotional picture or monetary gain) and/or
contrasted an active and a control condition (neutral
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picture or fixation cross); (7) coordinates were reported in
either standard Talairach space or Montreal Neurologic
Institute (MNI) space. Figure 1 shows the process of
study identification and selection. From the identification
and selection of studies, coordinate results of within-
group activations and between-group differences were di-
vided into 4 groups: activations in patients, activations in
healthy controls, increases in patients relative to controls,
and increases in controls relative to patients.
Activation likelihood estimation (ALE) procedure
Meta-analysis was performed using the ALE software imple-
mented in GingerALE version 2.3.2 (http://brainmap.org). This
Fig. 1 Flowchart describing the
process of study identification
and selection
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ALE version used a random effect model and weighted for
sample size of the original studies (Laird et al. 2005). In
ALE, activation foci reported in original studies are treated as
3D Gaussian distributions centered at the reported coordinates.
Activation probabilities are then calculated for each standard-
space voxel to construct ALE maps for contrasts of interest. To
determine the reliability of the ALE map, null-distributions are
generated by analyzing the distribution of ALE values across
independent studies, which is conceptually similar to using
permutation tests of individual voxels across experiments.
The observed values in the ALE distribution are then compared
to the null distribution in order to assign probability estimates to
the observed (experimental) data.
For the present meta-analysis, single studies were used re-
spectively to perform meta-analyses of anhedonia for each of
the three subdomains. Coordinates of the foci of activation
reported in MNI were transformed to Talairach space using
the icbm2tal in GingerALE. The threshold of statistical sig-
nificance was set at p<0.01 and corrected for multiple testing
using the false discovery rate (FDR) with a minimum cluster
size of 400 mm3. For visualization, whole-brain maps of
thresholded ALE maps were imported into multi-image anal-
ysis GUI (MANGO; http://ric.uthscsa.edu/mango) and
overlaid onto a standardized anatomical template in
Talairach space (www.brainmap.org/ale/colin1.1.nii).
Results
Article inclusion
Figure 1 shows the study selection flowchart, and Table 1
shows the pooled data for all contrasts. A total of 32 articles
with 684 healthy controls reporting 353 foci, and 28 articles
with 562 patients reporting 214 foci were included in within-
group analysis. A total of 57 articles (33 articles on MDD and
24 on SZ) with 986 patients and 1041 healthy controls and
reporting 453 foci were included in the transdiagnostic meta-
analysis. There were no significant differences in age or sex
between patients (34.33±8.55 years old; 51.09 % men) and
healthy controls (32.12±7.09 years old; 51.71 % men), MDD
patients (36.40±8.79 years old; 40.82 % men) and healthy
controls (33.85±8.42 years old; 39.80 % men) or between
SZ patients (30.75±6.96 years old; 63.64 % men) and healthy
controls (31.85±3.70 years old; 71.33 % men).
Within-group ALE analysis
Healthy controls
For reward consummatory (16 studies and 160 foci), ALE
revealed a set of subcortical areas, including bilateral
globus pallidus (GPe), bilateral red nucleus, right caudate
body, left substania nigra (SN) and right putamen, left
parahippocampal gyrus, as well as left medial frontal gyrus
(mPFC). For reward anticipation (17 studies and 99 foci),
ALE results showed robust activation of a broad cortical-
subcortical network, including left GPe, right caudate
head, left caudate body, bilateral red nucleus, right inferior
frontal cortex (IFG), right superior temporal gyrus (STG),
right insula, left mPFC and some midbrain areas, such as
mammillary body. For the emotional processing (9 studies
and 94 foci), several regions in frontal gyrus were activat-
ed to a greater degree, such as mPFC, MFG and IFG, as
well as the middle temporal gyrus and fusiform gyrus
(p<0.01, FDR corrected, cluster size>400 mm3, Table 2
and Fig. 2).
Patients (mixed MDD and SZ)
For reward consummatory (11 studies and 68 foci), ALE
analysis found seven statistically significant activation
clusters, including left GPe, right caudate head, left red
nucleus, right insula, left anterior cingulate gyrus (ACC),
IFG and amydala. Reward anticipation (14 studies and 63
foci) was related to the significant activation of putamen,
superior frontal gyrus (SFG) and IFG. As to the emotional
processing (7 studies and 83 foci), increased likelihood of
activation was observed in several frontal gyrus, temporal
gyrus, occipital gyrus, as well as caudate body (p<0.01,
FDR corrected, cluster size>400 mm3, Table 2 and
Fig. 2). The results of within-group analysis results in
MDD or SZ separately showed the similarly distribution
and activation pattern (details see Table S1 and Fig. S1).
Between-group ALE analysis in a transdiagnostic
approach across MDD and SZ
Consummatory anhedonia
For consummatory anhedonia (29 studies and 151 foci), ALE
analysis revealed five statistically significant clusters with de-
creased likelihood of activation in patients compared to con-
trols (Fig. 3 and Table 3), including bilateral caudate head and
body, bilateral GPe, left putamen, right red nucleus, left ven-
tral lateral nucleus and pulvinar, as well as MTG (p<0.01,,
FDR corrected, cluster size>400 mm3). No brain regions
showed increased likelihood of activation in patients com-
pared to controls.
Anticipatory anhedonia
For anticipatory anhedonia (30 studies and 119 foci), pre-
frontal cortex and striatal areas showed significantly differ-
ent activity (Fig. 3 and Table 3). Decreased likelihood of
activation was observed in bilateral caudate head, left
924 Brain Imaging and Behavior (2016) 10:920–939
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Table 2 Within-group ALE meta-analysis results in healthy controls and patients (mixed MDD and SZ)
Cluster Anatomical region BA X Y Z Volume mm3 Maximum ALE Value (10−3)
Healthy controls
Reward consummatory
1 R Lateral Globus Pallidus 10 6 −2 10384 25.07
L Lateral Globus Pallidus −10 4 0 24.63
L Parahippocampal Gyrus 34 −18 0 −12 13.16
R Caudate Body 8 18 6 12.73
2 L Medial Frontal Gyrus. −4 48 2 2864 21.02
3 R Red Nucleus 4 −22 −8 1432 14.40
L Red Nucleus −4 −16 −4 9.87
L Substania Nigra −8 −16 −12 8.77
4 R Putamen 26 0 −6 440 10.84
Reward anticipation
1 L Lateral Globus Pallidus −12 6 0 20736 49.99
R Caudate Head 10 6 0 46.31
R Red Nucleus 6 −26 −8 19.19
L Red Nucleus −6 −22 −8 14.62
L Caudate Body −12 4 18 11.84
R Subthalamic Nucleus 12 −12 −8 10.90
L Mammillary Body 0 −12 −10 10.89
R Mammillary Body 4 −12 −8 10.89
R Hypothalamus 10 −6 −8 10.87
2 R Inferior Frontal Gyrus 47 50 14 −2 712 12.80
R Superior Temporal Gyrus 38 52 18 −8 10.66
3 R Insula 13 36 16 6 552 11.67
4 L Medial Frontal Gyrus 10 −2 54 4 424 10.84
5 L Anterior Lobe.Culmen. 0 −60 −6 416 10.58
Emotional processing
1 L Medial Frontal Gyrus 32 −8 12 46 1000 18.60
2 R Posterior Lobe.Declive 34 −52 −12 768 20.80
3 L Medial Frontal Gyrus 9 0 46 32 688 16.68
4 L Inferior Frontal Gyrus −42 18 2 624 16.42
5 R Middle Temporal Gyrus 39 46 −72 14 528 16.92
6 R Fusiform Gyrus 19 24 −80 −10 560 16.04
7 R Inferior Frontal Gyrus 9 42 8 30 520 17.43
8 L Medial Frontal Gyrus 10 −2 60 −2 472 12.04
L Medial Frontal Gyrus 10 −2 50 −4 10.96
9 L Posterior Lobe.Declive. −30 −56 −14 456 17.93
10 R Cuneus 19 28 −84 32 496 17.23
11 R Anterior Cingulate 32 6 40 0 456 17.93
Patients (mixed MDD and SZ)
Reward consummatory
1 L Lateral Globus Pallidus −12 4 0 2456 13.93
L Parahippocampal Gyrus 34 −24 0 −10 13.69
L Putamen −14 8 −8 12.20
2 L Anterior Cingulate 10 −4 54 −2 1952 18.72
L Anterior Cingulate 24 −6 38 2 9.12
3 R Insula 13 38 4 −4 1544 14.48
4 R Amydala 22 −2 −10 1424 16.94
5 R Caudate Head 6 8 0 1192 16.25
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Table 2 (continued)
Cluster Anatomical region BA X Y Z Volume mm3 Maximum ALE Value (10−3)
6 L Red Nucleus 0 −22 −8 1144 11.76
7 L Inferior Frontal Gyrus 9 −54 12 30 488 12.78
Reward anticipation
1 R Putamen 14 8 −2 3168 29.48
2 L Putamen −14 10 −4 2536 16.57
3 R Inferior Frontal Gyrus 9 54 20 26 528 13.44
4 L Superior Frontal Gyrus 9 −1 49 32 400 10.66
Emotional processing
1 R Declive 34 −52 −12 1168 21.69
2 R Middle Temporal Gyrus 39 46 −72 14 816 17.43
3 R Inferior Frontal Gyrus 9 44 8 30 776 18.06
4 L Declive −30 −56 −14 680 18.96
5 R Cuneus 19 29 −85 32 576 17.52
6 L Caudate Body −18 20 14 496 11.39
7 L Middle Occipital Gyrus 19 −44 −78 2 432 11.38
8 L Superior Frontal Gyrus 9 −6 52 24 432 11.89
p<0.01, FDR corrected, cluster size >400 mm3 ; BA = Brodmann area
Fig. 2 Significant ALE maps
(FDR corrected, p<0.01, cluster
size >400 mm3) of within-group
analysis in healthy control group
(HC) and transdiagnostic patient
group (mixed MDD and SZ) for
reward consummatory, reward
anticipation, and emotional
processing
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putamen, right hippocampus and parahippocampus, ACC,
mPFC and MFG (p<0.01, FDR corrected, cluster size>
400 mm3). Increased likelihood of activation was observed
in the left IFG and MFG.
Emotional processing
For the emotional experience task (31 studies and 163 foci),
decreased likelihood of activation was observed in a number
of brain areas from the cortical-subcortical network (Fig. 3
and Table 3), including right GPe, right putamen, right medial
dorsal nucleus and ventrolateral nucleus of thalamus, bilateral
amygdala, left parahippocampal gyrus, right IFG, left mPFC,
left ACC and STG/MTG (p<0.01, FDR corrected, cluster
size>400 mm3). Increased likelihood of activation was ob-
served in the left middle occipital gyrus and fusiform gyrus.
Between-group ALE analysis in MDD or SZ
MDD
For consummatory anhedonia in MDD (21 studies and 107
foci), decreased likelihood of activation was observed in the
left GPe, right caudate body, left putamen, right insula and left
ACC (p<0.01, FDR corrected, cluster size>400 mm3;
Table S2 and Fig. 4). No areas with increased likelihood acti-
vation were observed.
For anticipatory anhedonia in MDD (17 studies and 89
foci), decreased likelihood of activation was observed in bi-
lateral caudate head and left MFG, and increased activation
was observed in left IFG and right MFG.
For emotional processing in MDD (25 studies and 124
foci), decreased likelihood of activation was observed in right
GPe and putamen, bilateral amygdala and anterior lobe, right
IFG and left ACC, and increased activation was observed in
middle occipital gyrus and fusiform gyrus.
SZ
For consummatory anhedonia in SZ (8 studies and 44 foci),
decreased likelihood of activation was observed in left puta-
men and caudate head, pulvinar and right red nucleus
(p<0.01, FDR corrected, cluster size>400 mm3; Table S3
and Fig. 4). No areas with increased likelihood of activation
were observed.
For anticipatory anhedonia in SZ (13 studies and 30 foci)
decreased likelihood of activation was observed in left puta-
men, ACC, and mPFC and right caudate head. No areas with
increased likelihood of activation were observed.
For emotional processing in SZ (6 studies and 39 foci),
decreased likelihood of activation was observed in the right
ventral lateral nucleus. No areas with increased likelihood of
activation were observed.
Discussion
This review used a transdiagnostic, meta-analytic approach
(ALE) to explore the neuronal basis of anhedonia across three
subdomains: consummatory anhedonia, anticipatory anhedo-
nia and emotional processing. Results revealed that consum-
matory anhedonia was associated with decreased activation in
ventral basal ganglia areas, ventral tegmental area (VTA) and
Fig. 3 Significant ALE maps
(FDR corrected, p<0.01, cluster
size >400 mm3) of between-
group analysis in a
transdiagnostic approach across
MDD and SZ for three
subdomains: (a) consummatory
anhedonia (b) anticipatory
anehdonia and (c) emotional
processing. Red and blue areas
depict regions with increased and
decreased likelihood of activation
in the healthy controls than that in
patients, respectively
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Table 3 ALE results in a transdiagnostic approach across MDD and SZ
Cluster Anatomical Region BA X Y Z Volume mm3 Maximum ALE Value (10−3)
Consummatory anhedonia
Control > patients
1 L Caudate Head −6 8 −2 4696 21.54
R Caudate Body 12 10 12 14.07
R Caudate Head 6 6 2 12.22
R Lateral Globus Pallidus 14 6 −6 11.06
R Caudate Body 10 16 −8 10.26
2 L Putamen −20 8 12 1216 18.35
L Putamen −26 2 4 10.70
L Putamen −24 4 −4 9.51
L Lateral Globus Pallidus −18 −4 8 9.25
3 R Red Nucleus 4 −22 −6 800 18.22
4 L Pulvinar −12 −24 4 608 14.71
LVentral Lateral Nucleus −10 −12 6 9.73
5 R Middle Temporal Gyrus 37 46 −56 2 496 16.42
Anticipatory anhedonia
Control > patients
1 R Caudate Head 8 12 −4 5248 21.63
L Putamen −14 8 −2 21.38
L Caudate Head −4 14 2 10.62
2 R Hippocampus 28 −20 −8 560 13.83
3 L Anterior Cingulate 32 0 46 8 560 9.84
L Medial Frontal Gyrus 10 −4 52 14 7.77
4 L Middle Frontal Gyrus 8 −32 14 52 488 11.88
5 R Parahippocampal Gyrus 19 22 −48 −4 464 10.95
Patients > control
1 R Middle Frontal Gyrus 9 38 26 38 560 13.87
2 L Inferior Frontal Gyrus 9 −46 12 30 504 13.98
Emotional processing
Control > patients
1 R Lateral Globus Pallidus 14 4 −4 2904 17.11
R Amygdala 20 −4 −12 15.81
R Putamen 20 14 −2 15.73
2 R Anterior Lobe. Culmen 6 −38 −4 1640 17.06
L Parahippocampal Gyrus 30 −6 −38 4 11.84
3 R Inferior Frontal Gyrus 47 26 32 −8 888 17.17
4 R Medial Dorsal Nucleus 12 −20 6 832 12.56
RVentral Lateral Nucleus 14 −16 14 11.42
5 L Medial Frontal Gyrus 9 −4 40 22 736 12.87
L Anterior Cingulate 32 −10 32 12 9.50
6 L Superior Temporal Gyrus 38 −46 14 −12 688 15.57
7 L Amygdala −18 −4 −14 448 16.22
8 L Middle Temporal Gyrus 22 −56 −28 0 400 15.16
Patients > control
1 L Middle Occipital Gyrus 37 −44 −66 −6 1160 13.15
L Fusiform Gyrus 19 −46 −74 −10 9.57
p<0.01, FDR corrected, cluster size >400 mm3 ; BA = Brodmann area
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various subcortical areas. Anticipatory anhedonia was related
to dysfunctions within basal ganglia regions like caudate and
putamen, as well as various subregions of prefrontal cortex,
such as anterior cingulate, medial frontal gyrus and middle
frontal gyrus. Emotional processing of positive-valence stim-
uli was related to more distributed dysfunction, involving
more of basal ganglia (putamen and GPe), thalamus, limbic
regions (amygdala and parahippocampal gyrus), prefrontal
cortex (IFG, mPFC, ACC), STG and middle occipital gyrus.
Meta-analyses of MDD and SZ respectively revealed similar
impairments in brain regions and activation patterns in con-
summatory and anticipatory anhedonia in these two diseases,
but differences in emotional processing.
The neural correlates of different reward processing
component
The within-group analysis results of healthy controls showed
that the three reward processing components related with anhe-
donia were differentially recruited the subregions in the basal
ganglia and forebrain. Specifically, the reward consummatory
processing was mainly concentrated on a series of subcortical
regions including GPe, ventral striatum, SN, as well as mPFC
and extended orbitofrontal cortex, which is consistent with a
number of animal and human studies (Der-Avakian and
Markou 2012). Recent researches suggests that the opioid and
GABA-ergic systems may play important role in that hedonic
Fig. 4 Significant ALE maps
(FDR corrected, p<0.01, cluster
size >400 mm3) of between-
group analysis in MDD or SZ
respectively for three
subdomains: (a) consummatory
anehdonia (b) anticipatory
anhedonia and (S) emotional
processing. Red areas depict the
regions with significant different
activation between MDD patients
and healthy controls. Green areas
depict regions with significant
different activation between SZ
patients and healthy controls.
ALE clusters are projected on a
standard anatomical template in
axial orientation, referring to
Talairach space
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responses (at least to primary sensory stimuli). On the other
side, reward anticipatory processing was more involved in dor-
sal striatum and cortical areas except for the ventral striatum and
medial profrontal areas,, such as inferior frontal gyrus and
insula. Those results highlighted importance of frontostriatal
circuitry in reward anticipatory/prediction processing (Barch
and Dowd 2010; Jarbo and Verstynen 2015) and indicated that
further investigation are needed on identifying the connectivites
between subareas of frontal cortex and striatum for specific
reward component. Unlike the neural correlates of reward con-
summatory and anticipation, the within-group analyses for
emotional processing task revealed much more widely distrib-
uted cortical areas in healthy controls, but not many subcortical
regions. Those results suggested that the activated brain areas in
emotional experience task may be the synthesis of various cog-
nitive and emotional response related with reward.
Furthermore, both the transdiagnostic analysis with mixed pa-
tients group and the analysis with MDD or SZ group separately
showed a similarly contributed but less activated pattern with
that of healthy controls in each of the subdomains of anhedonia.
Transdiagnostic neural markers of anhedonia
In both MDD and SZ, anhedonia is considered to be a core
clinical characteristic (Griffiths et al. 2014; Treadway et al.
2012; Wang et al. 2008). Animal studies have demonstrated
parallel substrates across different disorders associated with
altered anhedonia-related processing (Barr and Phillips
2002; Der-Avakian and Markou 2010). Therefore, researchers
suggested that common pathological mechanisms could
underlie anhedonia-related processing, supporting a
transdiagnostic approach to reveal these underlying cognitive
and neurobiological mechanisms. In this review, we applied
an ALE meta-analysis to MDD and SZ to provide an integrat-
ed framework of the neural bases of anhedonia.
Based on the results of this transdiagnostic meta-analysis,
consummatory anhedonia is related to decreased activation in
several subcortical regions, such as caudate head and body,
putamen, red nucleus, GPe, and pulvinar. Animal studies have
demonstrated involvement of the ventral striatum and ventral
pallidum in the experience of pleasure and hedonic perception
of rewards (Berridge and Kringelbach 2008; Kelley et al.
2002). Furthermore, patients with ventral pallidus damage have
significantly reduced responses to rewards or pleasant stimuli
(Miller et al. 2006; Vijayaraghavan et al. 2008). Consistent with
previous findings, our meta-analysis further implicated the opi-
oid and GABA-ergic systems in the nucleus accumbens shell
and its projections to the ventral pallidum, in deficits of in-the-
moment hedonic experience. Specifically, reduced caudate ac-
tivation has been reported to be associated with blunted pro-
cessing of incentive perception and reinforcement learning in
both MDD and SZ (Dowd and Barch 2010; Pizzagalli 2014;
Pizzagalli et al. 2009). A more recent conceptualization of
pulvinar function posited that this region plays an important
role in emotional salience and awareness (Hamilton et al.
2012; Pessoa and Adolphs 2010) and has strong bidirectional
connectivity with insula and dACC (Mufson and Mesulam
1984). Given this role of the pulvinar, we propose that low-
level pulvinar activation may blunt hedonic experience through
insufficient attention and awareness of reward-related informa-
tion. To summarize, ALE meta-analysis on consummatory an-
hedonia processing emphasized the critical role of ventral basal
ganglia and medial prefrontal pathways in generating the in-
the-moment hedonic value representation and experience.
For anticipatory anhedonia, ALE showed involvement of
the caudate and putamen, as well as several prefrontal subre-
gions, such as dACC (BA32), mPFC and MFG. Previous
studies suggested that multiple prefrontal-striatal pathways
and reciprocal connections within subregions of PFC play an
important role in regulating behavioral response to rewards or
pleasurable stimuli in the motivational/anticipatory stage
(Der-Avakian and Markou 2012; Salamone and Correa
2012). For instance, disruption of glutamatergic signaling be-
tween the mPFC and nucleus accumbens resulted in avolition
for rewards (Faure et al. 2010). Moreover, striatal lesions or
dopamine depletion in striatum or dACC impaired the com-
putation of effort-related costs, which then lead to a deficit of
effort-based decision-making as the expected rewards were
discounted (Croxson et al. 2009). Preclinical studies further
stressed that dACC plays an important role in signaling the net
value (benefits minus costs) during social interactions (Apps
and Ramnani 2014). In brief, during the anticipation stage for
reward or pleasurable stimuli, abnormal activation in mPFC,
dACC and MFGmay lead to failure to anticipate forthcoming
rewards, including updating/maintaining the value of pleasant
stimuli, effort-value computation, decision-making to engage
in goal-directed activity and monitoring incentive-based be-
havioral responses (Haber and Knutson 2010; Pujara and
Koenigs 2014; Wallis and Kennerley 2010). The results of
our meta-analysis consistently indicated that a number of
brain regions and pathways, involving many neurotransmitter
systems, mediated different aspects of anhedonia-related def-
icits. Consequently, this preliminary neural framework sup-
ports the conceptualization of anhedonia as a symptom with
multiple components. Rigorous experimental paradigms and
careful designs should be carried out in future work to provide
a more refined description of anhedonia and to separate the
neural bases of each aspect of anhedonia-related processing.
Our ALE analysis for anticipatory anhedonia also revealed
reduced activation of the hippocampus and parahippocampal
gyrus, which could impair retrieval of previous autobiographical
memories and their incorporation into working memory to rep-
resent the value of a reward and anticipate a pleasurable stimulus
(Adcock et al. 2006; Zhu et al. 2012; Mazgaj et al. 2015).
However, we did not observe any significant group difference
between patients and controls in orbitofrontal cortex (OFC),
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which is considered to be a key cortical region involved in an-
hedonia, in particular in the reward value presentation
(Kringelbach 2005; Pizzagalli 2014). One possible explanation
is that detection of OFC is challenging for functional MRI ex-
periments using regular EPI sequences due to strong magnetic
susceptibility variation near the air-filled sinuses and correspond-
ing signal loss and distortion (Faro et al. 2006; Osterbauer et al.
2006). Future investigation of this unique structure will benefit
from advances in imaging sequences or MRI hardware.
Given the complex neural pathways in the frontal-striatal-
thalamic circuitry, it is necessary to further divide each subcorti-
cal structure (e.g., striatum) into subregions to investigate the
function of different cortical-subcortical connections. For in-
stance, the striatum can be divided into three functional subre-
gions (i.e., limbic, associative and sensorimotor) based on affer-
ent inputs from the frontal cortex (Haber 2010; Haber et al. 2000;
Iversen 2010; van den Bos et al. 2014). Consummatory anhedo-
nia is mainly associated with limbic/ventral striatum, including
anterior and ventral caudate and putamen (Corral-Frias et al.
2015; Pizzagalli et al. 2009), whereas anticipatory anhedonia is
associated with both limbic/ventral striatum and associative stri-
atum, including the dorsal caudate and anterior part of the dorsal
putamen (Delgado 2007; Dichter et al. 2009; Mucci et al. 2015).
The results of our meta-analysis provide new evidence that dys-
function in distinct frontal-striatal pathways contributes to the
different components of anhedonia-related processing. Based
on this preliminary neural framework, further studies are needed
to identify the functional and structural connections underlying
these components of anhedonia-related processing.
ALE analysis of the emotional experience task revealedmore
widely distributed differences between patients and controls. In
addition to blunted activation in basal ganglia and thalamus, a
number of regions in limbic areas, prefrontal cortex, temporal
cortex, and cerebellum also showed decreased activation in pa-
tients, whereas the visual association cortices showed increased
activation. Given that the emotional experience task required no
response and may include various cognitive and affective com-
ponents, it is unclear whether those different activations reflect
only the neural bases of anhedonia. Recent resting-state fMRI
showed that different neural circuits were engaged in the emo-
tional task-general and emotion task-specific processing (Cole
et al. 2014), which would be differently activated by the emo-
tional experience task between controls and patients with affec-
tive symptoms.Moreover, functional connectivity analysis dem-
onstrated distinct circuits associated with severity of general
affective symptoms (i.e., depression) and anhedonia (Gabbay
et al. 2013). Indeed, a set of brain regions, including the anterior
and posterior cingulate, mPFC, basal ganglia and visual areas,
were activated during passive viewing of positive-valence stim-
uli, but the ventral striatum and mPFC were the key regions
correlated with self-reported anhedonia severity (Epstein et al.
2006;Harvey et al. 2010). Therefore, more elaborate experimen-
tal designs will be required to explore the underlying neural
bases of general mood-related processing and specific emotional
experiences (e.g., hedonia).
Disease-specific findings: MDD and SZ
To further explore anhedonia-related neural mechanisms and
identify potential disease-specific or task-specific con-
founders, ALE analysis was compared between MDD and
SZ patients across the three anhedonia subdomains. In gener-
al, anhedonia-related impairment was consistent between
MDD and SZ patients across the consummatory and anticipa-
tory stages. Those findings suggest that the neural substrates
involved in accurate appraisal of positive stimuli and genera-
tion of reward responses, but not the substrates underlying
hedonic emotion arousal, are likely to be the core brain areas
associated with anhedonia. Furthermore, these data provide a
partial explanation for the discordance between self-reported
trait pleasure and momentary pleasure in previous behavioral
studies: MDD and SZ patients reported normative affective
ratings in response to evocative laboratory stimuli, but low
positive affect and pleasurable experiences on evaluation of
inventories (Osuch et al. 2009; Pizzagalli 2010; Strauss 2013;
Treadway and Zald 2011). From a cognitive processing
pespective, laboratory-based assessment of consummatory
anhedonia may reflect the capacity for hedonic experience,
while the patient self-reports in clinical interviews and inven-
tories might reflect both the hedonic experience deficit and the
inability to accurately represent incentive experiences. Based
on this interpretation, the theoretical definition of anhedonia
for research and targeted treatment may need to be modified.
In contrast to the consummatory and anticipatory anhe-
donia domains, which were similar across MDD and SZ,
emotional experience tasks showed striking differences. In
MDD patients, decreased activation was much more wide-
ly distributed across brain regions, including basal gan-
glia, amygdala, frontal gyrus and cerebellum; SZ patients
only showed decreased activation in thalamus. As previ-
ously noted, the emotional experience task requires no
response and may reflect other cognitive and affective
components. Our results support that the emotional expe-
rience task induced both affective/mood-related and
anhedonia-specific responses. It is worth noting that only
blunted activation in part of ventral basal ganglia was cor-
related with anhedonia in MDD patients viewing positive
valence pictures (Epstein et al. 2006; Mitterschiffthaler
et al. 2003; Osuch et al. 2009), which was highly consis-
tent with the correlations between dysfunctional BOLD
signals and anhedonia in a consummatory anhedonia task
(Gradin et al. 2011; Pizzagalli et al. 2009). Overall, it ap-
pears that an emotional experience task, such as passively
viewing pictures or words, may not be a pure measure of
anhedonia (i.e., consummatory anhedonia) and may cap-
ture the affective responses related with general mood,
Brain Imaging and Behavior (2016) 10:920–939 933
which may influence results in populations with promi-
nent depressive symptoms.
Limitations
Potential limitations of this study should be noted. First of all,
ALE technique does have its own limitations. Unlike the
meta-analyses in which the complete activation maps are in-
cluded, the data used in ALE were based solely on reported
peak activation coordinates. Thereby ALE could not take into
account those studies without any significant clusters report-
ed, which may resulting in a systematic overestimation bias of
the results. Besides, the present ALE software cannot conduct
the correlation analysis or deal with covariates, thus the only
way to consider the covariates was run follow-up analyses,
e.g., only on experiments investigating only female subjects
or unmedicated patients when considering the gender or med-
ication effect. An additional limitation of the ALE is that it
may be unable to assess subtle methodological differences
in individual studies such as the thresholding used in the
original studies, relative strength of activations/differences
between groups and differences in preprocessing steps
(Radua and Mataix-Cols 2012). Nevertheless, previous
studies suggested that no individual study could signifi-
cantly bias the results of ALE meta-analyses after including
the sample size and number of reported foci into ALE al-
gorithm, changing from fixed-effects to random-effects in-
ference, and revising for multiple comparison correction
(Eickhoff et al. 2009; Turkeltaub et al. 2012; Eickhoff
et al. 2012; Kollndorfer et al. 2013). In the present study,
the robustness of results was further supported by the rea-
sonably coherent findings in within-group ALE analysis of
various reward processing components and between-group
analyses of subdomains of anhedonia, which were also con-
sistent with previous neurobioglogical studies on animals.
Secondly, given that the patients in 31/35 MDD studies and
22/25 SZ studies were treated in their lifetime by antidepressant
or antipsychotics, the drug effects on the brain activated pattern
in reward-related processing are potential confounding factors
which need to be addressed (Clarke et al. 2014; Boccia et al.
2015). Most antidepressant treatments act on the serotonergic or
noradrenergic circuits, but not directly enhance Dopamine (DA)
neurotransmission, which plays a significant role in motivation
and reward processing (Berridge 2007; Treadway and Zald
2011). However, recent literature showed that the antidepressant
mechanism such as increasing serotonin (5-HT) originating
from midbrain raphe nuclei (RN), could sequentially decrease
the dopamine inhibition and increased ventral striatal activity to
reward in humans and animals (Dremencov et al. 2005; Dunlop
and Nemeroff 2007; Ossewaarde et al. 2011; El Yacoubi et al.
2011). As for the antipsychotic treatment that directly impacts
the DA neurotransmission, evidence showed that the first gen-
eration (typical) and second generation (atypical) antipsychotic
medications had different effects on the neural correlates of
reward/motivation tasks (Juckel et al. 2006a, b; Kirsch et al.
2007; Schlagenhauf et al. 2008). For instance, Kirsch et al.
found that patients with typical antipsychotics showed reduced
ventral striatal activation, while atypically treated patients
showed significantly stronger activation of the right ventral stri-
atum. Those results were further supported by a controlled, lon-
gitudinal study (Nielsen et al. 2012a) . The different impact of
typical and atypical antipsychotics on reinforcement learning of
reward processing were also supported by both behavioral evi-
dences (Beninger et al. 2003;Keri et al. 2005) and neuroimaging
data (Insel et al. 2014). Further clinical and basic studies are
needed to reveal the underlying mechanism of those effects.
Conclusion and future directions
In summary, our ALE meta-analysis supported characteri-
zation of anhedonia by alterations in reward processing,
which contain multiple complicated components and rely
on many brain regions within frontal-striatal circuitry.
Specifically, consummatory anhedonia was associated with
decreased activation in ventral striatum and pallidum, while
anticipatory anhedonia was more associated with more sub-
strates in frontal-striatal networks except the ventral stria-
tum, which included the dorsal anterior cingulate, middle
frontal gyrus and medial frontal gyrus. However, the emo-
tional experience task (passive viewing of positive pictures
or words) revealed mixed findings, including dysfunction
in both the anhedonia-related and affective/mood process-
ing regions. Therefore, the transdiagnostic approach holds
promise for providing both overall and specific neurobio-
logical frameworks of anhedonia.
Although our meta-analysis presents novel, meaningful ev-
idence regarding the neurobiology of anhedonia, it only dis-
tinguished the neural substrates of motivation to pursue re-
wards and hedonic response to rewards. Future work is need-
ed to dissect the different neurobiological pathways that are
related to the various reward-processing subcomponents, such
as perceiving pleasure, encoding reward value, calculating
costs and benefits, learning from prior reinforcement, making
decisions and execute the action to pursue a reward. It is im-
portant to note that anhedonia also plays an important role in
several other psychiatric and neurological disorders, such as
Parkinson’s disease (Loas et al. 2012), post-traumatic stress
disorder (Frewen et al. 2012) and drug addiction (Balodis and
Potenza 2015; Hatzigiakoumis et al. 2011), albeit in heteroge-
neous ways. Therefore, combining more categories of disor-
ders and using a greater sample size in future studies should
further elucidate the neural foundations of anhedonia.
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